You have 9 free searches left this month | for more free features.

PCWG3

Showing 1 - 25 of 434

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Castration-Resistant Prostate Cancer Trial in China, United States (ZEN003694, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • San Francisco, California
  • +21 more
Aug 18, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +8 more
Jan 17, 2023

Prostatic Tumors, Castration-Resistant Trial in Worldwide (Atezolizumab, Enzalutamide)

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Duarte, California
  • +157 more
Oct 26, 2022

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Finland, Netherlands, United Kingdom (BAY3546828, BAY2616505,

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Helsinki, Finland
  • +3 more
Sep 18, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Prostate Cancer Trial (Lutetium Lu 177 JH020002 Injection)

Not yet recruiting
  • Prostate Cancer
  • Lutetium Lu 177 JH020002 Injection
  • (no location specified)
Nov 14, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Metastatic Castration Resistant Prostate Cancer Trial in United States (VERU-111)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Golden, Colorado
  • +12 more
Mar 28, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Cabozantinib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Nov 10, 2022

Prostate Cancer Trial in Long Beach, West Los Angeles, Hines (stereotactic ablative radiotherapy, Pluvicto, topical

Not yet recruiting
  • Prostate Cancer
  • stereotactic ablative radiotherapy
  • +2 more
  • Long Beach, California
  • +2 more
Oct 13, 2023

Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)

Recruiting
  • Metastatic Prostate Cancer
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 17, 2023

Solid Tumors Trial in Charlottesville (XmAb662, Keytruda® (pembrolizumab))

Recruiting
  • Solid Tumors
  • XmAb662
  • Keytruda® (pembrolizumab)
  • Charlottesville, Virginia
    University Of Virginia Comprehensive Cancer Center
Aug 10, 2023

Metastatic Castration-Resistant Prostate Cancer Patients Trial in Copenhagen (Irofulven, Prednisolone 10 mg)

Active, not recruiting
  • Metastatic Castration-Resistant Prostate Cancer Patients
  • Copenhagen, Denmark
    Rigshospitalet, Dept. Of Oncology
Feb 1, 2023

Prostate Cancer Trial in United States (DKN-01 300 mg, DKN-01 600 mg, Docetaxel 75 mg/m2)

Terminated
  • Prostate Cancer
  • San Francisco, California
  • +4 more
Jan 30, 2023

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

Recruiting
  • Neoplasms
  • +13 more
  • HTL0039732 Capsules
  • HTL0039732 Capsules and atezolizumab infusion
  • Cambridge, United Kingdom
  • +4 more
Jul 5, 2023

Solid Tumor, Adult Trial in Shanghai (3D011-08)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Floor 2, Building 2, 270 Dong 'an Road, Xuhui District, China
    Fudan University Shanghai Cancer Center
Jan 2, 2023

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Phase I and Phase II: LAE001/prednisone + afuresertib
    • Tucson, Arizona
    • +16 more
    Nov 30, 2022

    Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +8 more
    • XmAb®808
    • Keytruda® (pembrolizumab)
    • Denver, Colorado
    • +2 more
    Jan 19, 2023

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial (HS-10502)

    Not yet recruiting
    • Ovarian Cancer
    • +4 more
    • (no location specified)
    Feb 24, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Jun 15, 2023